Synthesis and antitumor activity of 9-acyloxyellipticines

Chemical and Pharmaceutical Bulletin

Volumn 45, Issue 7, 1997, Pages 1156-1162

  Harada, Naoyuki ^a   Ozaki, Kunihiko ^a   Oda, Kouji ^a   Nakanishi, Noriyuki ^a   Ohashi, Motoaki ^a   Hashiyama, Tomiki ^a   Tsujihara, Kenji ^a  

^a MITSUBISHI TANABE PHARMA CORPORATION   (Japan)

Author keywords

9 Acyloxyellipticine; B16 melanoma; Lewis lung carcinoma; P388 leukemia; Water soluble antitumor substance

Indexed keywords

ANTINEOPLASTIC AGENT; ELLIPTICINE DERIVATIVE; GLUTARIC ACID DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; DRUG EFFECT; DRUG SCREENING; DRUG SYNTHESIS; INTRAVENOUS DRUG ADMINISTRATION; LEUKEMIA P 388; LEWIS CARCINOMA; MALE; MELANOMA B16; MOUSE; NONHUMAN;

EID: 0030786374     PISSN: 00092363     EISSN: None     Source Type: Journal    
DOI: 10.1248/cpb.45.1156     Document Type: Article

References (17)

1. Harada N., Kawaguchi T., Inoue I., Oda K., Ohashi M., Hashiyama T., Tsujihara K., Chem. Pharm. Bull., 45, 134-137 (1997).
2. 2) was dissolved in water and the solution was allowed to stand at room temperature for 1 h, affording 2 in 72% yield.
3. Juret P., Tanguy A., Girard A., LeTalaer J. Y., Abbatucci J. S., Eur. J. Cancer, 14, 205-206 (1978).
4. Honda T., Kato M., Inoue M., Shimamoto T., Shima K., Nakanishi T., Yoshida T., Noguchi T., J. Med. Chem., 31, 1295-1305 (1988).
5. Ohashi M., Sugikawa E., Nakanishi N., Jpn. J. Cancer Res., 86, 819-827 (1995).
6. Guthrie R. W., Brossi A., Mennona F. A., Mullin J. G., Kierstead R. W., Grunberg E., J. Med. Chem., 18, 755-760 (1975). They synthesized 9-acetoxy, propoxy, isobutyroxy and caproxy ellipticine derivatives and tested these compounds for antitumor activity against sarcoma 180.
7. Suffness M., "The Alkaloids," Vol. 25, ed. by Brossi A., Academic Press, Inc., New York, 1985, pp. 89-304; Gribble G. W., ibid., Vol. 39, 307-352 (1990); Kansal V. K., Potier P., Tetrahedron, 42, 2389-2408 (1986); Gouyette A., Reynaud R., Sadet J., Baillarge M., Gansser C., Cros S., Goffic F., Pecq J.-B., Paoletti C., Viel C., Eur. J. Med. Chem., 15, 503-510 (1980).
8. Suffness M., "The Alkaloids," Vol. 25, ed. by Brossi A., Academic Press, Inc., New York, 1985, pp. 89-304; Gribble G. W., ibid., Vol. 39, 307-352 (1990); Kansal V. K., Potier P., Tetrahedron, 42, 2389-2408 (1986); Gouyette A., Reynaud R., Sadet J., Baillarge M., Gansser C., Cros S., Goffic F., Pecq J.-B., Paoletti C., Viel C., Eur. J. Med. Chem., 15, 503-510 (1980).
9. Suffness M., "The Alkaloids," Vol. 25, ed. by Brossi A., Academic Press, Inc., New York, 1985, pp. 89-304; Gribble G. W., ibid., Vol. 39, 307-352 (1990); Kansal V. K., Potier P., Tetrahedron, 42, 2389-2408 (1986); Gouyette A., Reynaud R., Sadet J., Baillarge M., Gansser C., Cros S., Goffic F., Pecq J.-B., Paoletti C., Viel C., Eur. J. Med. Chem., 15, 503-510 (1980).
10. Suffness M., "The Alkaloids," Vol. 25, ed. by Brossi A., Academic Press, Inc., New York, 1985, pp. 89-304; Gribble G. W., ibid., Vol. 39, 307-352 (1990); Kansal V. K., Potier P., Tetrahedron, 42, 2389-2408 (1986); Gouyette A., Reynaud R., Sadet J., Baillarge M., Gansser C., Cros S., Goffic F., Pecq J.-B., Paoletti C., Viel C., Eur. J. Med. Chem., 15, 503-510 (1980).
11. a) Dalton L. K., Demerac S., Elmes B. C., Loder J. W., Swan J. M., Teitei T., Aust. J. Chem., 20, 2715-2727 (1967);
12. b) Griffle G. W., Saulnier M. G., Obaza-Nutaitis J. A., Ketcha D. M., J. Org. Chem., 57, 5891-5899 (1992);
13. c) Anderson W. K., Gopalsamy A., Reddy P. S., J. Med. Chem., 37, 1955-1963 (1994).
14. Plug J. P. M., Koomen G.-J., Pandit U. K., Synthesis 1221-1222 (1992).
15. Oku A., Harada T., Kita K., Tetrahedron Lett., 23, 681-684 (1982).
16. o-Dichlorobenzene (60%), dichloroethane and fluorobenzene (<50%).
17. Compound 5o was more stable in phosphate buffer (pH 4.0) at 40°C (86% remained after 10 h).